Blue Owl Capital Inc. · OWL · FY2026 Q2 · Calendar Q3 2026
Blue Owl sustains fundraising and fee-margin momentum in Q2 2026
The quarter supports a constructive view of Blue Owl’s earnings trajectory: diversified platforms, continued fundraising and a 58.5% fee-related earnings margin provide support, while redemptions, rates and deployment risks remain relevant.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about OWL FY2026 Q2
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Management highlighted 9% year-over-year fee-related earnings growth, $16.5 billion of Q2 capital raised and easing wealth-channel redemptions. Real assets reached nearly 30% of AUM, and $31 billion of AUM was not yet fee-paying.
Guidance delta
Guidance was maintained at a 58.5% fee-related earnings margin, with modest upside expected.
Key takeaways
- Fee-related earnings grew 9% year over year across real assets, alternative credit and direct lending.
- Blue Owl raised $16.5 billion in Q2 and $50.5 billion year to date, with institutional and overseas investors contributing.
- Net lease and digital infrastructure were highlighted as sources of returns and new capital.
- Management said wealth-channel redemptions have eased and inflows are stabilizing.
- Non-fee-paying AUM represents a potential source of future management fees, but conversion timing was not specified.
Management priorities
- Complete fundraising and capital calls for Net Lease Fund VI by year-end.
- Pursue a first close for the next digital infrastructure flagship later this year.
- Expand GP stakes and BOSE offerings.
- Broaden wealth-product distribution across advisory platforms.
- Evaluate a traditional drawdown direct-lending product.
Follow OWL with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 31, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| BMO Capital | Outperform | Outperform | Maintain | Oct 27, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Oct 19, 2026 |
| TD Cowen | Buy | Buy | Maintain | Oct 12, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Aug 27, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Aug 3, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 31, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Jul 9, 2026 |
| UBS | Neutral | Neutral | Maintain | May 1, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | May 1, 2026 |
| Deutsche Bank | Hold | Buy | Downgrade | Feb 24, 2026 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Feb 19, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jan 22, 2026 |
| Citigroup | Buy | Buy | Maintain | Oct 13, 2025 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | May 23, 2025 |
| Keefe, Bruyette & Woods | Outperform | Market Perform | Upgrade | May 20, 2025 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Apr 8, 2025 |
| RBC Capital | Outperform | Outperform | Maintain | May 26, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | May 8, 2023 |
| B of A Securities | Buy | Buy | Maintain | Jan 24, 2022 |
Named analyst price targets
Upside is calculated against the persisted current price $10.33. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wells Fargo | Analyst unavailable | $10 | $8.95 | -3.2% | Oct 1, 2026 |
| HSBC | Analyst unavailable | $17 | $9.6 | +64.6% | Sep 24, 2026 |
| Capital One Financial | Analyst unavailable | $12 | $10.3 | +16.2% | Aug 3, 2026 |
| Goldman Sachs | Analyst unavailable | $10.5 | $10.3 | +1.6% | Aug 3, 2026 |
| Capital One Financial | Analyst unavailable | $11 | $9.32 | +6.5% | Jul 13, 2026 |
| Barclays | Benjamin Budish | $9 | $9.28 | -12.9% | Jul 9, 2026 |
| Credit Suisse | Analyst unavailable | $9.1 | $9.06 | -11.9% | Jul 2, 2026 |
| UBS | Michael Brown | $9.5 | $9.42 | -8.0% | Jun 11, 2026 |
| Barclays | Benjamin Budish | $10 | $9.75 | -3.2% | May 1, 2026 |
| Deutsche Bank | Brian Bedell | $10 | $10.44 | -3.2% | Feb 24, 2026 |
| UBS | Analyst unavailable | $12 | $11.18 | +16.2% | Feb 20, 2026 |
| Evercore ISI | Analyst unavailable | $14 | $12.45 | +35.5% | Feb 6, 2026 |
| Goldman Sachs | Analyst unavailable | $14 | $11.63 | +35.5% | Feb 6, 2026 |
| Piper Sandler | Crispin Love | $15 | $11.63 | +45.2% | Feb 6, 2026 |
| Barclays | Analyst unavailable | $15 | $11.63 | +45.2% | Feb 6, 2026 |
| Evercore ISI | Analyst unavailable | $17 | $15.86 | +64.6% | Jan 22, 2026 |
| Oppenheimer | Analyst unavailable | $27 | $15.86 | +161.4% | Jan 20, 2026 |
| UBS | Michael Brown | $16.5 | $15.5 | +59.7% | Jan 13, 2026 |
| Barclays | Analyst unavailable | $18 | $15.78 | +74.2% | Jan 9, 2026 |
| Wolfe Research | Analyst unavailable | $20 | $15.52 | +93.6% | Jan 7, 2026 |
| Goldman Sachs | Alexander Blostein | $16.25 | $15.87 | +57.3% | Jan 6, 2026 |
| UBS | Michael Brown | $18 | $16.56 | +74.2% | Dec 11, 2025 |
| Raymond James | Analyst unavailable | $20 | $16.67 | +93.6% | Dec 10, 2025 |
| Evercore ISI | Glenn Schorr | $19 | $15.71 | +83.9% | Oct 31, 2025 |
| Oppenheimer | Analyst unavailable | $25 | $15.86 | +142.0% | Oct 31, 2025 |
| Barclays | Benjamin Budish | $19 | $15.86 | +83.9% | Oct 31, 2025 |
| Piper Sandler | Crispin Love | $22 | $16.51 | +113.0% | Oct 9, 2025 |
| Barclays | Benjamin Budish | $21 | $16.11 | +103.3% | Oct 8, 2025 |
| Oppenheimer | Chris Kotowski | $24 | $17.1 | +132.3% | Apr 16, 2025 |
| Oppenheimer | Chris Kotowski | $21 | $16.26 | +103.3% | Aug 2, 2024 |
| Deutsche Bank | Brian Bedell | $21 | $18.31 | +103.3% | Apr 18, 2024 |
| Piper Sandler | Crispin Love | $23 | $19.34 | +122.7% | Apr 10, 2024 |
| Evercore ISI | Glenn Schorr | $22 | $19.38 | +113.0% | Apr 4, 2024 |
| UBS | Brennan Hawken | $22 | $18.57 | +113.0% | Apr 2, 2024 |
| Wolfe Research | Steven Chubak | $22 | $18.24 | +113.0% | Mar 22, 2024 |
| Deutsche Bank | Brian Bedell | $19 | $11.65 | +83.9% | Sep 12, 2022 |
Track every rating change on OWL the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationBlue Owl Capital Inc., an asset management firm based in New York City, leverages a robust and permanent capital base to deliver a comprehensive suite of financial solutions. It serves a diverse clientele, including mid-sized businesses, leading alternative asset managers, and corporate real estate owners and tenants. The company's offerings encompass direct lending products, providing private credit options such as diversified, technology-focused, first lien, and opportunistic financing for middle-market companies. Additionally, it offers GP capital solutions, extending financial backing to major private capital managers through services like minority equity investments, GP debt financing, and stakes in professional sports organizations. Blue Owl also provides real estate-focused products, primarily involving the structuring of sale-leaseback transactions, often featuring triple net leases. These diverse solutions are made available through permanent capital vehicles and long-term private investment funds.
Historical context
All OWL earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| ERIE Erie Indemnity Company | FY2026 Q3 · Calendar Q4 2026 | +2.1% | +5.3% | Erie pairs resilient demand initiatives with thin underwriting margins |
| CBOE Cboe Global Markets, Inc. | FY2026 Q3 · Calendar Q4 2026 | — | +7.8% | Cboe pairs broad growth with new products and higher guidance |
| NWG NatWest Group plc | FY2026 Q3 · Calendar Q4 2026 | — | -9.1% | NatWest keeps guidance as deposits and wealth management expand |
| COIN Coinbase Global, Inc. | FY2026 Q3 · Calendar Q4 2026 | +1189.2% | -10.6% | Coinbase offsets lower spot trading with prediction markets and AI agents |
| TPG TPG Inc. | FY2026 Q3 · Calendar Q4 2026 | +4.3% | +7.5% | TPG raises FRE margin outlook as capital formation accelerates |
| AJG Arthur J. Gallagher & Co. | FY2026 Q3 · Calendar Q4 2026 | +0.3% | +2.9% | AJG: Q3 growth and AssuredPartners synergies support outlook |
Latest beats and misses
Who reports nextBeat on EPS
- WYFY2026 Q3 · October 29, 2026+128.3% EPS+3.0% move
- LNTFY2026 Q3 · October 29, 2026+16.0% EPS+1.4% move
- MTZFY2026 Q3 · October 29, 2026+0.3% EPS+0.8% move
- ERIEFY2026 Q3 · October 29, 2026+2.1% EPS+5.3% move
- IRFY2026 Q3 · October 29, 2026+18.5% EPS+0.2% move
- VLTOFY2026 Q3 · October 29, 2026+8.3% EPS+9.8% move
Get the OWL recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-08-14T17:18:12.626589+00:00
- FN2 earnings calendar · 2026-09-04T01:23:15.205020+00:00
- Polygon adjusted daily market bars · 2026-10-31T01:30:44.253054+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-31T01:30:44.249433+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-31. For educational purposes only; not investment advice.